Surgeon experience and complications of transvaginal prolapse mesh

Obstetrics and Gynecology

Volumn 128, Issue 1, 2016, Pages 65-72

  Kelly, Erin C ^a   Winick Ng, Jennifer ^a   Welk, Blayne ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; COHORT ANALYSIS; COMORBIDITY; FEMALE; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MEDICAL DEVICE COMPLICATION; OUTCOME ASSESSMENT; PELVIC ORGAN PROLAPSE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURGEON; SURGICAL MESH; WORK EXPERIENCE; ADVERSE EFFECTS; HEALTH PERSONNEL ATTITUDE; MIDDLE AGED; ONTARIO; POSTOPERATIVE COMPLICATIONS; PROCEDURES; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

AGED; ATTITUDE OF HEALTH PERSONNEL; FEMALE; HUMANS; MIDDLE AGED; ONTARIO; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PELVIC ORGAN PROLAPSE; POSTOPERATIVE COMPLICATIONS; REOPERATION; RETROSPECTIVE STUDIES; SURGEONS; SURGICAL MESH; SURGICAL PROCEDURES, OPERATIVE;

EID: 84973387048     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000001450     Document Type: Article

References (30)

1. Wu JM, Matthews CA, Conover MM, Pate V, Jonsson Funk M. Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstet Gynecol 2014;123:1201-6.
2. Fialkow MF, Newton KM, Weiss NS. Incidence of recurrent pelvic organ prolapse 10 years following primary surgical management: a retrospective cohort study. Int Urogynecol J Pelvic Floor Dysfunct 2008;19:1483-7.
3. Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 1997;89:501-6.
4. Vaginal placement of synthetic mesh for pelvic organ prolapse. Committee Opinion No. 513. American College of Obstetricians and Gynecologists. Obstet Gynecol 2011;118:1459-64.
5. Rogo-Gupta L, Rodriguez LV, Litwin MS, Herzog TJ, Neugut AI, Lu YS, et al. Trends in surgical mesh use for pelvic organ prolapse from 2000 to 2010. Obstet Gynecol 2012;120: 1105-15.
6. Maher C, Feiner B, Baessler K, Christmann-Schmid C, Haya N, Marjoribanks J. Transvaginal mesh or grafts compared with native tissue repair for vaginal prolapse. The Cochrane Database of Systematic Reviews 2016, Issue 2. Art. No.: CD012079. DOI: 10.1002/14651858.CD012079.
7. Urogynecologic surgical mesh: update on the safety and effectiveness of transvaginal placement for pelvic organ prolapse. Silver Spring (MD): U.S. Food and Drug Administration; 2011. Available at: http://www.fda.gov/downloads/medicaldevices/safety/alertsandnotices/UCM262760.pdf. Retrieved August 17, 2015.
8. Surgical mesh-complications associated with transvaginal implantation for the treatment of stress urinary incontinence and pelvic organ prolapse-notice to hospitals-recalls & alerts-Healthy Canadians. Ottowa (Canada): Health Canada; 2014. Available at: http://www.healthycanadians.gc.ca/recall-Alert-rappelavis/hc-sc/2014/39475a-eng.php. Retrieved August 17, 2015.
9. Pickett SD, Barenberg B, Quiroz LH, Shobeiri SA, O'Leary DE. The significant morbidity of removing pelvic mesh from multiple vaginal compartments. Obstet Gynecol 2015;125:1418-22.
10. Dunn GE, Hansen BL, Egger MJ, Nygaard I, Sanchez-Birkhead AC, Hsu Y, et al. Changed women: the long term impact of vaginal mesh complications. Female Pelvic Med Reconstr Surg 2014;20:131-6.
11. FDA strengthens requirements for surgical mesh for the transvaginal repair of pelvic organ prolapse to address safety risks. Silver Spring (MD): U.S. Food and Drug Administration; 2016. Available at: http://www.fda.gov/NewsEvents/Newsroom/Press-Announcements/ucm479732.htm. Retrieved February 27, 2016.
12. Raina P, Torrance-Rynard V, Wong M, Woodward C. Agreement between self-reported and routinely collected health-care utilization data among seniors. Health Serv Res 2002;37:751-74.
13. Williams JI, Young W. A summary of studies on the quality of health care administrative databases in Canada. In: Goel V, Williams JI, Anderson GM, Fooks C, Blackstien-Hirsch P, Naylor CD, editors. Patterns of health care in Ontario. 2nd ed. Toronto (Canada): ICES; 1996:339-47.
14. Jha P, Deboer D, Sykora K, Naylor CD. Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: a population-based comparison. J Am Coll Cardiol 1996;27:1335-42.
15. Nguyen JN, Jakus-Waldman SM, Walter AJ, White T, Menefee SA. Perioperative complications and reoperations after incontinence and prolapse surgeries using prosthetic implants. Obstet Gynecol 2012;119:539-46.
16. Diwadkar GB, Barber MD, Feiner B, Maher C, Jelovsek JE. Complication and reoperation rates after apical vaginal prolapse surgical repair: a systematic review. Obstet Gynecol 2009;113:367-73.
17. Segal J, Sacopulos M, Sheets V, Thurston I, Brooks K, Puccia R. Online doctor reviews: do they track surgeon volume, a proxy for quality of care? J Med Internet Res 2012;14:e50.
18. McAlister FA, Youngson E, Bakal JA, Holroyd-Leduc J, Kassam N. Physician experience and outcomes among patients admitted to general internal medicine teaching wards. CMAJ 2015;187:1041-8.
19. Weiner J. The Johns Hopkins ACG system reference manual, version 8.2. 2008. Available at: http://www.ensolution.se/upl/files/14429.pdf. Retrieved February 27, 2015.
20. Austin PC, van Walraven C, Wodchis WP, Newman A, Anderson GM. Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a general adult population cohort in Ontario, Canada. Med Care 2011;49:932-9.
21. Matheson FI, Dunn JR, Smith K, Moineddin R, Glazier RH. Development of the Canadian Marginalization Index: a new tool for the study of inequality. Can J Public Health 2012;103 (suppl 2):S12-6.
22. Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput 2009;38:1228-34.
23. Jonsson Funk M, Visco AG, Weidner AC, Pate V, Wu JM. Long-Term outcomes of vaginal mesh versus native tissue repair for anterior vaginal wall prolapse. Int Urogynecol J 2013;24: 1279-85.
24. Barski D, Otto T, Gerullis H. Systematic review and classification of complications after anterior, posterior, apical, and total vaginal mesh implantation for prolapse repair. Surg Technol Int 2014;24:217-24.
25. Deng T, Liao B, Luo D, Shen H, Wang K. Risk factors for mesh erosion after female pelvic floor reconstructive surgery: a systematic review and meta-Analysis. BJU Int 2016;117:323-43.
26. Shah HN, Badlani GH. Mesh complications in female pelvic floor reconstructive surgery and their management: a systematic review. Indian J Urol 2012;28:129-53.
27. Sirls LT, McLennan GP, Killinger KA, Boura JA, Fischer M, Nagaraju P, et al. Exploring predictors of mesh exposure after vaginal prolapse repair. Female Pelvic Med Reconstr Surg 2013;19:206-9.
28. Gold KP, Ward RM, Zimmerman CW, Biller DH, McGuinn S, Slaughter JC, et al. Factors associated with exposure of transvaginally placed polypropylene mesh for pelvic organ prolapse. Int Urogynecol J 2012;23:1461-6.
29. Frankman EA, Alperin M, Sutkin G, Meyn L, Zyczynski HM. Mesh exposure and associated risk factors in women undergoing transvaginal prolapse repair with mesh. Obstet Gynecol Int 2013;2013:926313.
30. Withagen MI, Vierhout ME, Hendriks JC, Kluivers KB, Milani AL. Risk factors for exposure, pain, and dyspareunia after tension-free vaginal mesh procedure. Obstet Gynecol 2011;118:629-36.